Peptide Comparison
UrocortinvsThymosin Beta-4
A powerful stress-response peptide that protects your heart and helps your body handle pressure
The body's natural healing peptide that accelerates tissue repair and reduces inflammation
At a Glance
Quick
comparison
Dose Range
Urocortin
As prescribed–As prescribed mg
Thymosin Beta-4
2–5 mg
Frequency
Urocortin
Once daily
Thymosin Beta-4
Twice weekly
Administration
Urocortin
As directed by healthcare provider
Thymosin Beta-4
Subcutaneous injection
Cycle Length
Urocortin
Ongoing/indefinite
Thymosin Beta-4
8-12 weeks
Onset Speed
Urocortin
Moderate (1-2 weeks)
Thymosin Beta-4
Moderate (1-2 weeks)
Evidence Level
Urocortin
Moderate human trials (Phase 1-2)
Thymosin Beta-4
Moderate human trials (Phase 1-2)
Efficacy
Benefit
ratings
Cardiovascular Protection
Stress Response & Resilience
Heart Function Support
Wound Healing
Inflammation Reduction
Tissue Regeneration
Technical Data
Compound
specifications
Urocortin
Molecular Formula
C216H329N59O64S
Molecular Weight
Approximately 4,700 Daltons
Half-Life
Approximately 2-6 hours (varies by route of administration)
Bioavailability
Varies by route of administration
CAS Number
173190-76-4
Thymosin Beta-4
Molecular Formula
C212H350N56O78S
Molecular Weight
4963
Half-Life
Dose-dependent (increases with higher doses)
Bioavailability
100% (subcutaneous and intravenous)
CAS Number
77591-33-4
Applications
Best
suited for
Urocortin
Supporting cardiovascular health during stressful periods
Urocortin is particularly well-suited for individuals focused on supporting cardiovascular health during stressful periods. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Improving heart function in those with weakened hearts
Urocortin is particularly well-suited for individuals focused on improving heart function in those with weakened hearts. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Enhancing stress resilience and coping
Urocortin is particularly well-suited for individuals focused on enhancing stress resilience and coping. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Optimizing blood vessel and circulation function
Urocortin is particularly well-suited for individuals focused on optimizing blood vessel and circulation function. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Thymosin Beta-4
Post-Surgery Recovery
Accelerates healing of surgical wounds and reduces post-operative inflammation and scarring
Chronic Wound Management
Helps pressure ulcers, venous stasis ulcers, and other slow-healing wounds progress faster
Tissue Regeneration
Supports repair of damaged tissues from injury, burns, or degenerative conditions
Safety Profile
Side
effects
Urocortin
Common
- Facial flushing
- Mild headache
- Dizziness
- Injection site response
- Nausea
Serious
- Severe allergic reaction
- Severe blood pressure changes
- Heart palpitations
Thymosin Beta-4
Common
- Injection site redness
- Injection site swelling
Uncommon
- Temporary mild headache
- Mild bruising at injection site
- Transient fatigue
Serious
- Allergic reaction
Research Status
Safety
& evidence
Urocortin
Evidence Level
Moderate human trials (Phase 1-2)
FDA Status
Research compound
Safety Overview
Urocortin III (a corticotropin-releasing factor analogue) shows preclinical safety in animal models with potential CNS and cardiovascular effects through CRF receptor activation. No completed human clinical trials exist—all human data comes from limited Phase 1 safety/tolerability work in small populations. Expected adverse effects based on CRF physiology include anxiety/panic-like symptoms (paradoxical, due to CRF's role in stress response), hypothalamic-pituitary-adrenal (HPA) axis effects, and cardiovascular responses (blood pressure, heart rate changes). Neurotoxicity and excitotoxicity are theoretical concerns requiring electrolyte and cardiac monitoring.
Contraindications
- xHypersensitivity to urocortin or CRF-related peptides
- xSevere hypertension without medical monitoring
- xAcute coronary syndrome (heart attack) - requires careful evaluation
- xUncontrolled arrhythmias
- xPregnancy and breastfeeding (limited safety data)
Thymosin Beta-4
Evidence Level
Moderate human trials (Phase 1-2)
FDA Status
Research compound
Safety Overview
Thymosin Beta-4 is a naturally occurring peptide found in all cells and body fluids in the human body. Clinical trials have demonstrated excellent safety even at very high doses. IV studies showed doses up to 1260 mg were well tolerated with no serious adverse events.
Contraindications
- xActive systemic infections
- xSevere immunosuppression
- xHypersensitivity to thymosin or any component
- xPregnancy (insufficient safety data)
Decision Guide
Which is
right for you?
Choose Urocortin if...
- Supporting cardiovascular health during stressful periods
- Improving heart function in those with weakened hearts
- Enhancing stress resilience and coping
- Optimizing blood vessel and circulation function
Choose Thymosin Beta-4 if...
- Recovering from injuries or surgery
- Improving wound healing speed
- Reducing inflammation
- Minimizing scar formation